yttrium radioisotopes has been researched along with Neutropenia in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (12.50) | 18.2507 |
| 2000's | 9 (56.25) | 29.6817 |
| 2010's | 5 (31.25) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Izumitani, S; Matsuo, H; Saeki, Y; Sakurashita, H; Taogoshi, T; Yoshikawa, H | 1 |
| Botto, B; Carella, AM; Cascavilla, N; Ciabatti, E; Ciochetto, C; Fraternali Orcioni, G; Galimberti, S; Guolo, F; Ibatici, A; Nati, S; Orciuolo, E; Petrini, M; Pica, GM; Vitolo, U; Zinzani, PL | 1 |
| Andrade-Campos, MM; Baringo, T; Giraldo, P; Grasa, JM; Lopez-Gómez, L; Montes-Limón, AE; Soro-Alcubierre, G | 1 |
| Bondiau, PY; Broglia, JM; Carrier, P; Darcourt, J; Fontana, X; Gressin, R; Lepeu, G; Peyrade, F; Peyrottes, I; Slama, B; Thyss, A; Triby, C | 1 |
| Bekaii-Saab, T; Gold, DV; Goldenberg, DM; Goldsmith, SJ; Guarino, MJ; Gulec, SA; Hall, N; Holt, M; Horne, H; Kauh, J; Lee, D; Manzone, T; Montero, AJ; O'Neil, BH; Ocean, AJ; Pennington, KL; Serafini, AN; Sheikh, A; Sung, MW; Wegener, WA | 1 |
| Cilley, J; Evens, AM; Gallot, L; Gordon, LI; Larson, A; Patton, D; Rademaker, A; Roy, R; Spies, S; Variakojis, D; Winter, JN | 1 |
| Ansell, SM; Habermann, TM; Ristow, KM; Wiseman, GA; Witzig, TE | 1 |
| Gregory, SA | 1 |
| Bartlett, NL; Blum, KA | 1 |
| Chew, HK; DeNardo, GL; Denardo, SJ; Goldstein, DS; Kukis, DL; Lamborn, KR; Lara, PN; Meares, CF; Natarajan, A; O'Donnell, RT; Richman, CM; Shen, S; Tuscano, JM; Wun, T; Yuan, A | 1 |
| Dietlein, M; Engert, A; Eschner, W; Fischer, T; Pinkert, J; Schicha, H; Schnell, R; Schomäcker, K; Zimmermanns, B | 1 |
| Busby, E; Carey, D; Forero, A; Grizzle, WE; Khazaeli, MB; LoBuglio, AF; Meredith, RF; Robert, F; Shen, S | 1 |
| Baccarani, M; Derenzini, E; Fanti, S; Fina, M; Musuraca, G; Perrotti, A; Stefoni, V; Tani, M; Vitolo, U; Zinzani, PL | 1 |
| Alinari, L; Baccarani, M; Bacci, F; Castellucci, P; de Vivo, A; Derenzini, E; Fanti, S; Farsad, M; Fina, M; Marchi, E; Musuraca, G; Pellegrini, C; Pileri, S; Stefoni, V; Tani, M; Zinzani, PL | 1 |
| Behr, T; Blumenthal, RD; Goldenberg, DM; Haywood, L; Sharkey, RM | 1 |
| Brechbiel, MW; Bukowski, MA; Clark, R; Dirbas, FM; Gansow, OA; Garmestani, K; Goldman, CK; Parenteau, GL; Waldmann, TA | 1 |
3 review(s) available for yttrium radioisotopes and Neutropenia
| Article | Year |
|---|---|
Radioimmunotherapy in relapsed follicular lymphoma previously treated by autologous bone marrow transplant: a report of eight new cases and literature review.
Topics: Aged; Antibodies, Monoclonal; Bone Marrow Transplantation; Female; Humans; Lymphoma, Follicular; Male; Middle Aged; Neutropenia; Radioimmunotherapy; Retrospective Studies; Salvage Therapy; Shock, Septic; Thrombocytopenia; Transplantation, Autologous; Treatment Outcome; Yttrium Radioisotopes | 2008 |
Selecting patients for treatment with 90Y ibritumomab tiuxetan (Zevalin).
Topics: Antibodies, Monoclonal; Antigens, CD20; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Neutropenia; Patient Selection; Thrombocytopenia; Yttrium Radioisotopes | 2003 |
90Yttrium-ibritumomab tiuxetan: a novel treatment for non-Hodgkin's lymphoma.
Topics: Animals; Antibodies, Monoclonal; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Forecasting; Humans; Immunoconjugates; Lymphoma, Non-Hodgkin; Mice; Neutropenia; Radioimmunotherapy; Radiotherapy Dosage; Thrombocytopenia; Treatment Outcome; Yttrium Radioisotopes | 2004 |
7 trial(s) available for yttrium radioisotopes and Neutropenia
| Article | Year |
|---|---|
Safety and efficacy of (90) yttrium-ibritumomab-tiuxetan for untreated follicular lymphoma patients. An Italian cooperative study.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Female; Humans; Lymphoma, Follicular; Male; Middle Aged; Neoplasm Staging; Neutropenia; Pilot Projects; Radiation Injuries; Radioimmunotherapy; Remission Induction; Survival Analysis; Thrombocytopenia; Treatment Outcome; Yttrium Radioisotopes | 2014 |
Fractionated radioimmunotherapy with (90) Y-clivatuzumab tetraxetan and low-dose gemcitabine is active in advanced pancreatic cancer: A phase 1 trial.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antimetabolites, Antineoplastic; Carcinoma, Pancreatic Ductal; Combined Modality Therapy; Deoxycytidine; Female; Gemcitabine; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neutropenia; Pancreatic Neoplasms; Radiation Dosage; Radiation-Sensitizing Agents; Radioimmunotherapy; Thrombocytopenia; Yttrium Radioisotopes | 2012 |
Bortezomib may be safely combined with Y-90-ibritumomab tiuxetan in patients with relapsed/refractory follicular non-Hodgkin lymphoma: a phase I trial of combined induction therapy and bortezomib consolidation.
Topics: Adult; Aged; Antibodies, Monoclonal; Antineoplastic Agents; Boronic Acids; Bortezomib; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Humans; Induction Chemotherapy; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Pyrazines; Radioimmunotherapy; Recurrence; Treatment Outcome; Yttrium Radioisotopes | 2013 |
High-dose radioimmunotherapy combined with fixed, low-dose paclitaxel in metastatic prostate and breast cancer by using a MUC-1 monoclonal antibody, m170, linked to indium-111/yttrium-90 via a cathepsin cleavable linker with cyclosporine to prevent human
Topics: Adult; Aged; Aged, 80 and over; Animals; Antibodies, Monoclonal; Antineoplastic Agents, Phytogenic; Bone Neoplasms; Breast Neoplasms; Cathepsins; Combined Modality Therapy; Cyclosporine; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Female; Heterocyclic Compounds, 1-Ring; Humans; Indium Radioisotopes; Male; Mice; Middle Aged; Neutropenia; Paclitaxel; Prostatic Neoplasms; Radioimmunotherapy; Soft Tissue Neoplasms; Treatment Outcome; Yttrium Radioisotopes | 2005 |
Phase I study of 90Y-CC49 monoclonal antibody therapy in patients with advanced non-small cell lung cancer: effect of chelating agents and paclitaxel co-administration.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Neoplasm; Antigens, Neoplasm; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chelating Agents; Clinical Trials as Topic; Disease Progression; Edetic Acid; Female; Glycoproteins; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Neutropenia; Paclitaxel; Pentetic Acid; Radioimmunotherapy; Radiometry; Thrombocytopenia; Treatment Outcome; Up-Regulation; Yttrium Radioisotopes | 2005 |
A phase 2 trial of fludarabine and mitoxantrone chemotherapy followed by yttrium-90 ibritumomab tiuxetan for patients with previously untreated, indolent, nonfollicular, non-Hodgkin lymphoma.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Neutropenia; Radioimmunotherapy; Survival Analysis; Treatment Outcome; Vidarabine; Yttrium Radioisotopes | 2008 |
A phase II trial of CHOP chemotherapy followed by yttrium 90 ibritumomab tiuxetan (Zevalin) for previously untreated elderly diffuse large B-cell lymphoma patients.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Feasibility Studies; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Neutropenia; Prednisone; Prognosis; Prospective Studies; Radioimmunotherapy; Remission Induction; Thrombocytopenia; Treatment Outcome; Vincristine; Yttrium Radioisotopes | 2008 |
6 other study(ies) available for yttrium radioisotopes and Neutropenia
| Article | Year |
|---|---|
Safety of
Topics: Aged; Aged, 80 and over; Anemia; Antibodies, Monoclonal; Asian People; Female; Humans; Japan; Leukopenia; Lymphoma; Male; Middle Aged; Neutropenia; Radiopharmaceuticals; Retrospective Studies; Safety; Thrombocytopenia; Treatment Outcome; Yttrium Radioisotopes | 2019 |
Long-term efficacy of (90)Y ibritumomab tiuxetan therapy in follicular non-Hodgkin lymphoma and health-related quality of life.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antibody-Dependent Cell Cytotoxicity; Antigens, CD20; Antigens, Neoplasm; Disease-Free Survival; Drug Evaluation; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lymphoma, Follicular; Male; Middle Aged; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Neutropenia; Quality of Life; Radioimmunotherapy; Remission Induction; Rituximab; Thrombocytopenia; Yttrium Radioisotopes | 2014 |
Subsequent chemotherapy regimens are well tolerated after radioimmunotherapy with yttrium-90 ibritumomab tiuxetan for non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Female; Fever; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Radioimmunotherapy; Retrospective Studies; Salvage Therapy; Treatment Outcome; Yttrium Radioisotopes | 2002 |
[Radioimmunotherapy with yttrium-90 ibritumomab tiuxetan. Clinical considerations, radiopharmacy, radiation protection, perspectives].
Topics: Anemia; Antibodies, Monoclonal; Chromatography, High Pressure Liquid; Humans; Lymphoma; Neutropenia; Quality Control; Radiation Protection; Radioimmunotherapy; Radionuclide Imaging; Thrombocytopenia; Yttrium Radioisotopes | 2005 |
Application of cytokine intervention for improved radio-antibody dose delivery.
Topics: Animals; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Immunoglobulin Fab Fragments; Immunoglobulin G; Interleukin-1; Iodine Radioisotopes; Leukocyte Count; Mice; Mice, Inbred BALB C; Neutropenia; Radioimmunotherapy; Rhenium; Thrombocytopenia; Yttrium Radioisotopes | 1997 |
Prolongation of graft survival in primate allograft transplantation by yttrium-90-labeled anti-Tac in conjunction with granulocyte colony-stimulating factor.
Topics: Animals; Antibodies, Monoclonal; Graft Survival; Granulocyte Colony-Stimulating Factor; Haplorhini; Humans; Neutropenia; Organ Transplantation; Radiation Injuries, Experimental; Receptors, Interleukin-2; Transplantation, Homologous; Yttrium Radioisotopes | 1992 |